NLRP1 L155H polymorphism is a risk factor for preeclampsia development


Autoria(s): Pontillo, Alessandra; Reis, Edione C.; Bricher, Pamela N.; Vianna, Priscila; Diniz, Solange; Fernandes, Karla S.; Chies, José A.; Sandrim, Valeria
Contribuinte(s)

Universidade Estadual Paulista (UNESP)

Data(s)

21/10/2015

21/10/2015

01/06/2015

Resumo

Problem: Augmented levels of IL-1 ss have been pointed out as an important pathogenic factor for preeclampsia development. Inflammasome is the cytoplasmic complex responsible for pro-IL1 ss cleavage and IL-1 ss secretion. Aim of the study was to evaluate the association between polymorphisms in inflammasome'genes and preeclampsia. Method of study: Selected polymorphisms in inflammasome genes (NLRP1, NLRP3, CARD8, and IL1B) were analyzed in 286 Brazilian women with and 309 without preeclampsia. Results and Conlclusions: The NLRP1 variant rs12150220 (L155H) was associated with the development of preeclampsia (OR=1.58), suggesting a role of this inflammasome receptor in the pathogenesis of this multifactorial disorder.

Formato

577-581

Identificador

http://onlinelibrary.wiley.com/doi/10.1111/aji.12353/abstract

American Journal Of Reproductive Immunology. Hoboken: Wiley-blackwell, v. 73, n. 6, p. 577-581, 2015.

1046-7408

http://hdl.handle.net/11449/128571

http://dx.doi.org/10.1111/aji.12353

WOS:000354390000010

Idioma(s)

eng

Publicador

Wiley-Blackwell

Relação

American Journal Of Reproductive Immunology

Direitos

closedAccess

Palavras-Chave #IL-1 ss #Inflammasome #NLRP1 #Preeclampsia
Tipo

info:eu-repo/semantics/article